Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen

We evaluate the prognostic value of chemotherapy and other prognostic factors on overall survival among colon patients with deficient mismatch repair (dMMR), and determine the optimum time to start chemotherapy after surgery. Data of 306 colon cancer patients with dMMR who received radical surgery w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Yixiang, Ni, Kemin, Liu, Zhaoce, xin, Ran, Han, Qiurong, Ping, Hangyu, Liu, Yaohong, Zhao, Xuanzhu, Wang, Wanting, Yan, Suying, Sun, Jing, Zhang, Qinghuai, Wang, Guihua, Zhang, Zili, Zhang, Xipeng, Hu, Xia, Li, Guoxun, Zhang, Chunze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238399/
https://www.ncbi.nlm.nih.gov/pubmed/37268749
http://dx.doi.org/10.1038/s41598-023-33153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238399/
https://www.ncbi.nlm.nih.gov/pubmed/37268749
http://dx.doi.org/10.1038/s41598-023-33153-8

Ejemplares similares